BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 34 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,217,394 | +42.9% | 14,404,000 | 0.0% | 0.45% | +40.7% |
Q2 2023 | $11,346,287 | +6.3% | 14,404,000 | 0.0% | 0.32% | +8.2% |
Q1 2023 | $10,673,364 | +62.3% | 14,404,000 | -1.4% | 0.29% | +74.4% |
Q4 2022 | $6,574,950 | -24.8% | 14,611,000 | 0.0% | 0.17% | -24.0% |
Q3 2022 | $8,749,000 | +8.1% | 14,611,000 | 0.0% | 0.22% | +12.8% |
Q2 2022 | $8,091,000 | -5.2% | 14,611,000 | 0.0% | 0.20% | +161.3% |
Q1 2022 | $8,533,000 | -20.8% | 14,611,000 | 0.0% | 0.08% | -15.7% |
Q4 2021 | $10,771,000 | -46.7% | 14,611,000 | 0.0% | 0.09% | -53.2% |
Q3 2021 | $20,195,000 | -16.0% | 14,611,000 | 0.0% | 0.19% | -15.9% |
Q2 2021 | $24,035,000 | +20.3% | 14,611,000 | +21.0% | 0.23% | +54.8% |
Q1 2021 | $19,978,000 | – | 12,076,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,655,000 | $82,515,000 | 3.29% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $131,952,000 | 2.77% |
Aequim Alternative Investments LP | 22,000,000 | $36,397,000 | 2.35% |
WOLVERINE ASSET MANAGEMENT LLC | 66,696,000 | $110,306,000 | 0.93% |
Polar Asset Management Partners Inc. | 50,000,000 | $82,872,000 | 0.82% |
Castle Creek Arbitrage, LLC | 6,500,000 | $10,746,000 | 0.62% |
Soleus Capital Management, L.P. | 1,950,000 | $3,216,000 | 0.58% |
WESTWOOD HOLDINGS GROUP INC | 16,000,000 | $26,497,000 | 0.27% |
Nicholas Investment Partners, LP | 2,100,000 | $3,464,000 | 0.24% |
Magnetar Financial LLC | 14,500,000 | $24,028,000 | 0.23% |